BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | ₹5.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹6.17 Cr |
Mar2021 | ₹2.00 Cr |
Mar2020 | ₹5.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | 67.43 | |
Mar2023 | ₹10 Cr | 69.85 | |
Mar2022 | ₹6.17 Cr | 208.45 | |
Mar2021 | ₹2.00 Cr | -60.00 | |
Mar2020 | ₹5.00 Cr | - |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹194.4 Cr | 10.8% | 10.1% | -9.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,320.0 Cr | 0.9% | -0.1% | 10.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,823.0 Cr | 3.7% | 3% | 46.5% | Stock Analytics | |
CIPLA | ₹121,591.0 Cr | 0.2% | 2.8% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,400.0 Cr | 7.3% | 7.4% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,135.0 Cr | -4% | 2.6% | 7.2% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 10.8% |
10.1% |
-9.7% |
SENSEX | 2.1% |
2.4% |
7.1% |
You may also like the below Video Courses